short term trading week starting - 10th feb, page-160

Pils, first thought is the risk that the CE Mark is not granted. Disastrous scenario. Such a brilliant product at the mercy of bureaucracy while sick people wait in the wings.......typical. Next is the cost and timing of US trials. On the plus side, the figures are outstanding and the market is truly limitless. I will put some thought into it and chat again in the weekend thread.